Together we will beat cancer

Donate

ASCO 2021 news: follow-up treatments pave the way

One of the biggest meetings of the world’s cancer specialists took place this weekend. Usually located in Chicago, researchers and clinicians around the world met virtually this year to present the latest in cancer research at the American Society of Clinical Oncology (ASCO) annual meeting. Here’s a flavour of the some of the top research presented.

Read More

COVID-19 vaccine and cancer – latest updates

Recently, news of a COVID-19 vaccine has dominated headlines. We’ve summarised all the information that is out there, with rolling updates, in our new vaccine blog post.

Read More

Catch up on Behind the Science 2021 – From funding stream to blood stream: Is drug development moving fast enough?

This year’s event took place virtually on Wednesday 12 May. Watch or listen back now.

Read More

A tribute to Professor Gordon McVie

Almost 20 years since Cancer Research UK was founded, not many who worked with McVie remain, but staff know him as the man who gave the charity its beginning.

Read More

NICE approves new maintenance treatment for ovarian cancer

A new targeted treatment has been recommended by the National Institute of Health and Care Excellence for some adults with ovarian cancer.

Read More

Discovering the BRCA2 gene – 25 years on

25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off.

Read More

Cancer Research UK forced to cut research funding due to COVID-19

Due to the effects of COVID-19, Cancer Research UK has had to cut its research funding by £45 million.

Read More

Opinion: ‘Let’s not be short-sighted – the UK’s medical research charities need urgent support’

Today’s new figures, from the UK’s National Cancer Research Institute, project a devastating 24% drop in the UK’s overall cancer research spending this year, driven by a 46% fall in charity sector funding.

Read More

PARP inhibitors: Halting cancer by halting DNA repair

How researchers supported by Cancer Research UK pioneered the development of PARP inhibitors.

Read More

Breast and ovarian cancer drug effective in advanced prostate cancer

A targeted cancer drug, already licensed for treating some breast and ovarian cancers, is found to be effective for some men with advanced prostate cancer.

Read More